Torrent Pharmaceuticals has fully redeemed commercial paper (CP) worth Rs 300 crore. The CP was issued on November 24, 2017, having maturity date of May 23, 2018.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.